Who is sponsoring NCT02292745?

NCT02292745 is sponsored by Foundation for Liver Research.

What drugs are being tested in NCT02292745?

Interventions in NCT02292745: stereotactic radiotherapy.

What condition does NCT02292745 study?

NCT02292745 studies Pancreatic Neoplasms.

Is NCT02292745 still recruiting?

NCT02292745 is currently completed. Last updated 29 July 2020.

Last reviewed 2020-07-29 · How we verify

NCT02292745: LAPC-1

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer.

Completed NA Last updated 29 July 2020

What this trial tests

NA trial testing stereotactic radiotherapy in Pancreatic Neoplasms in 53 participants. Completed in 24 May 2018.

Timeline

2 December 2014

Primary endpoint
24 May 2018

24 May 2018

Quick facts

Lead sponsor	Foundation for Liver Research
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	53
Start date	2 December 2014
Primary completion	24 May 2018
Estimated completion	24 May 2018
Sites	1 location across Netherlands

Drugs / interventions tested

stereotactic radiotherapy

Conditions studied

Pancreatic Neoplasms — all drugs for Pancreatic Neoplasms →

Sponsor

Foundation for Liver Research

Who can join

Adults 18 to 75, any sex, with Pancreatic Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to investigate whether combining FOLFIRINOX chemotherapy and stereotactic radiotherapy in patients with locally advanced pancreatic cancer leads to an increase in survival.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians.
Spadi R, Brusa F, Ponzetti A, Chiappino I, et al · · 2016 · cited 64× · PMID 26862489 · DOI 10.5306/wjco.v7.i1.27
Efficacy and feasibility of stereotactic radiotherapy after folfirinox in patients with locally advanced pancreatic cancer (LAPC-1 trial).
Suker M, Nuyttens JJ, Eskens FALM, Haberkorn BCM, et al · · 2019 · cited 50× · PMID 31891135 · DOI 10.1016/j.eclinm.2019.10.013

Verify or expand the search:

Other trials of stereotactic radiotherapy

Trials testing the same drug.

NCT03963726 — Clinical Efficacy of Stereotactic Radiotherapy and Microwave Ablation for Liver Metastases From Colorectal Cancer. · NA · unknown
NCT03921957 — Study of the Decrease of Length of Stereotactic Body Radiation Therapy in Lung Cancer · NA · unknown

Other recruiting trials for Pancreatic Neoplasms

Currently open trials in the same condition.

NCT07504471 — Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhib · Phase 2 · recruiting
NCT07139236 — Preoperative EUS Elastography for Pancreatic Texture and POPF Prediction After PD · recruiting
NCT06885697 — Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Includi · Phase 1 · recruiting
NCT06939023 — Laparoscopic Versus Robot-assisted Left-sided Pancreatectomy for Benign and Pre-malignant Lesions (DIPLOMA-3) · NA · recruiting
NCT06953193 — Intraoperative Hypotension in Pancreatoduodenectomy: A Randomized Trial of General Versus Combined Anesthesia · NA · recruiting

Other Foundation for Liver Research trials

Trials by the same sponsor.

NCT03120195 — EndoRotor® Ablation of Barrett's Esophagus: Safety and Feasibility Study · NA · completed
NCT01373684 — PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients · Phase 4 · completed
NCT01958190 — Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus · Phase 4 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02292745 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Foundation for Liver Research
Last refreshed: 29 July 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02292745.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing